These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Sudden death at young age and the importance of molecular-pathologic investigation]. Wilde AA; van Langen IM; Mannens MM; Waalewijn RA; Maes A Ned Tijdschr Geneeskd; 2005 Jul; 149(29):1601-4. PubMed ID: 16078763 [TBL] [Abstract][Full Text] [Related]
3. The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening. Christiaans I; Birnie E; van Langen IM; van Spaendonck-Zwarts KY; van Tintelen JP; van den Berg MP; Atsma DE; Helderman-van den Enden AT; Pinto YM; Hermans-van Ast JF; Bonsel GJ; Wilde AA Eur Heart J; 2010 Apr; 31(7):842-8. PubMed ID: 20019025 [TBL] [Abstract][Full Text] [Related]
4. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene. Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405 [TBL] [Abstract][Full Text] [Related]
5. Hypertrophic cardiomyopathy: case report. Mukhtar AU; Ihunwo AO East Afr Med J; 1999 Sep; 76(9):535-6. PubMed ID: 10685328 [TBL] [Abstract][Full Text] [Related]
6. The pathology of hypertrophic cardiomyopathy. Hughes SE Histopathology; 2004 May; 44(5):412-27. PubMed ID: 15139989 [TBL] [Abstract][Full Text] [Related]
7. [Hypertrophic cardiomyopathy: DNA diagnosis, genetic counselling and the risk of sudden cardiac death]. Baars HF; Christiaans I; de Nijs PT; Cramer MJ; van Langen IM; Doevendans PA Ned Tijdschr Geneeskd; 2010; 154():A698. PubMed ID: 20132578 [TBL] [Abstract][Full Text] [Related]
8. [High-risk hypertrophic cardiomyopathy associated with a novel mutation in cardiac Myosin-binding protein C]. García-Pavía P; Segovia J; Molano J; Mora R; Kontny F; Erik Berge K; Leren TP; Alonso-Pulpón L Rev Esp Cardiol; 2007 Mar; 60(3):311-4. PubMed ID: 17394878 [TBL] [Abstract][Full Text] [Related]
9. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy. Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239 [TBL] [Abstract][Full Text] [Related]
10. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. Monserrat L; Hermida-Prieto M; Fernandez X; Rodríguez I; Dumont C; Cazón L; Cuesta MG; Gonzalez-Juanatey C; Peteiro J; Alvarez N; Penas-Lado M; Castro-Beiras A Eur Heart J; 2007 Aug; 28(16):1953-61. PubMed ID: 17611253 [TBL] [Abstract][Full Text] [Related]
11. Molecular autopsy in young sudden cardiac death victims with suspected cardiomyopathy. Larsen MK; Nissen PH; Berge KE; Leren TP; Kristensen IB; Jensen HK; Banner J Forensic Sci Int; 2012 Jun; 219(1-3):33-8. PubMed ID: 22177269 [TBL] [Abstract][Full Text] [Related]
12. Hypertrophic cardiomyopathy linked to homozygosity for a new mutation in the myosin-binding protein C gene (A627V) suggests a dosage effect. García-Castro M; Reguero JR; Alvarez V; Batalla A; Soto MI; Albaladejo V; Coto E Int J Cardiol; 2005 Jul; 102(3):501-7. PubMed ID: 16004897 [TBL] [Abstract][Full Text] [Related]
13. The role of molecular autopsy in unexplained sudden cardiac death. Tester DJ; Ackerman MJ Curr Opin Cardiol; 2006 May; 21(3):166-72. PubMed ID: 16601452 [TBL] [Abstract][Full Text] [Related]
14. The development of familial hypertrophic cardiomyopathy: from mutation to bedside. Brouwer WP; van Dijk SJ; Stienen GJ; van Rossum AC; van der Velden J; Germans T Eur J Clin Invest; 2011 May; 41(5):568-78. PubMed ID: 21158848 [TBL] [Abstract][Full Text] [Related]
16. Hypertrophic cardiomyopathy and athlete's heart: a tale of two entities. Martín M; Reguero JJ; Castro MG; Coto E; Hernández E; Carro A; Calvo D; de la Tassa CM Eur J Echocardiogr; 2009 Jan; 10(1):151-3. PubMed ID: 18713777 [TBL] [Abstract][Full Text] [Related]
17. [A frame shift mutation, Arg346fs mutation, is identified in cardiac myosin-binding protein C gene in a Chinese family with hypertrophic cardiomyopathy]. Xie WL; Liu WL; Hu DY; Cui W; Zhu TG; Li CL; Sun YH; Li L; Bian H Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):963-6. PubMed ID: 16061003 [TBL] [Abstract][Full Text] [Related]
18. A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy. Meurs KM; Sanchez X; David RM; Bowles NE; Towbin JA; Reiser PJ; Kittleson JA; Munro MJ; Dryburgh K; Macdonald KA; Kittleson MD Hum Mol Genet; 2005 Dec; 14(23):3587-93. PubMed ID: 16236761 [TBL] [Abstract][Full Text] [Related]
19. Familial and sporadic hypertrophic myopathy: differences and similarities in a genotyped population. A long follow-up study. Brito D; Richard P; Komajda M; Madeira H Rev Port Cardiol; 2008 Feb; 27(2):147-73. PubMed ID: 18488914 [TBL] [Abstract][Full Text] [Related]
20. Homozygous mutation of MYBPC3 associated with severe infantile hypertrophic cardiomyopathy at high frequency among the Amish. Zahka K; Kalidas K; Simpson MA; Cross H; Keller BB; Galambos C; Gurtz K; Patton MA; Crosby AH Heart; 2008 Oct; 94(10):1326-30. PubMed ID: 18467358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]